What is the appropriate dose of sulfatrim (trimethoprim‑sulfamethoxazole) for a 10‑year‑old child?

Sulfatrim Dosing for a 10-Year-Old Child

For most common pediatric infections (urinary tract infections, acute otitis media, shigellosis), the standard dose is 40 mg/kg/day of sulfamethoxazole and 8 mg/kg/day of trimethoprim, divided into two doses given every 12 hours. 1

Weight-Based Dosing Guidelines

For a typical 10-year-old child weighing approximately 30-40 kg (66-88 lbs), the FDA-approved dosing is: 1

• 30 kg (66 lbs): 3 teaspoonfuls (15 mL) every 12 hours
• 40 kg (88 lbs): 4 teaspoonfuls (20 mL) every 12 hours

The total daily dose should not exceed 320 mg trimethoprim with 1600 mg sulfamethoxazole. 1

Indication-Specific Dosing

Standard Infections (UTI, Otitis Media, Shigellosis)

• Duration: 10-14 days for UTI, 5 days for shigellosis 1
• Dose: 40 mg/kg sulfamethoxazole + 8 mg/kg trimethoprim per 24 hours, divided every 12 hours 1

Pneumocystis Pneumonia Treatment

If treating documented PCP (rare in immunocompetent children): 1

• Higher dose required: 75-100 mg/kg sulfamethoxazole + 15-20 mg/kg trimethoprim per 24 hours
• Frequency: Divided into 4 doses given every 6 hours
• Duration: 14-21 days 1

PCP Prophylaxis

For immunocompromised children requiring prophylaxis: 2, 1

• Dose: 750 mg/m²/day sulfamethoxazole + 150 mg/m²/day trimethoprim
• Schedule: Given in divided doses twice daily on 3 consecutive days per week 1
• Alternative: 150 mg TMP with 750 mg SMX/m² per day, 3 days per week 2

Important Safety Considerations

Contraindications: 1

• Not recommended for children less than 2 months of age
• Avoid in severe renal impairment (creatinine clearance <15 mL/min)

Monitoring requirements: 2

• Complete blood counts with differential and platelet count should be performed at initiation and monthly intervals to assess for hematologic toxicity, particularly neutropenia 2
• This is especially important as drug-induced myelosuppression is a recognized risk 2

Renal dose adjustment: 1

• Creatinine clearance 15-30 mL/min: Use half the usual regimen
• Creatinine clearance <15 mL/min: Not recommended

Clinical Pitfalls to Avoid

Resistance concerns: In certain populations (particularly oncology/transplant patients), trimethoprim-sulfamethoxazole has potential for increased resistance in colonizing organisms and is not preferred for antibacterial prophylaxis in those settings. 2

Adverse effects: 3

• TMP-SMX has been associated with higher rates of adverse events compared to alternative antibiotics in some pediatric populations
• Common reactions include rash, neutropenia, and gastrointestinal symptoms
• If life-threatening toxicity occurs (anaphylaxis, Stevens-Johnson syndrome, hypotension), permanently discontinue 2

Drug interruption: If desensitization is performed after an adverse reaction, TMP-SMX must be given daily thereafter due to potential for serious reactions upon reintroduction after any dosing interruption. 2